PBYI

Puma Biotechnology Stock Analysis

AI Rating

Good
  • Quality9/10
  • Growth 6/10
  • Value 4/10
Puma Biotechnology sales and earnings growth
PBYI Growth
Good
  • Revenue Y/Y -4.81%
  • EPS Y/Y -35.06%
  • FCF Y/Y 71.96%
Puma Biotechnology gross and profit margin trends
PBYI Profitability
Good
  • Gross margin 74.50%
  • EPS margin 10.70%
  • ROIC 5Y 42.52%
Puma Biotechnology net debt vs free cash flow
PBYI Risk
Great
  • Debt / Equity 0.1
  • Debt / FCF 0.0
  • Interest coverage 6.6

Puma Biotechnology stock is less volatile than the overall market, so it's low risk. We give it a Great risk rating.

↗ More Biotechnology stocks